ONTOLOGY REPORT - ANNOTATIONS
| Term: | ranitidine |
|
| Accession: | CHEBI:8776
|
browse the term
|
| Definition: | A furan that has formula C13H22N4O3S. |
| Synonyms: | exact_synonym: | (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine |
| | related_synonym: | C13H22N4O3S; CN\\C(NCCSCc1ccc(CN(C)C)o1)=C/[N+]([O-])=O; InChI=1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+; InChIKey=VMXUWOKSQNHOCA-UKTHLTGXSA-N; ranitidina; ranitidinum |
| | xref_casrn: | 66357-35-5 |
| | xref: | Beilstein:4327819 "Beilstein Registry Number"; ChEMBL:110685 "ChEMBL COMPOUND"; ChemIDplus:66357-35-5 "CAS Registry Number"; DrugBank:DB00863 "DrugBank"; KEGG DRUG:D00422 "KEGG DRUG" |
| | xref_mesh: | MESH:D011899 |
| | xref: | Patent:FR2384765 "Patent"; Patent:US4128658 "Patent"; Wikipedia:Ranitidine "Wikipedia" |
|
|
ranitidine
|
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
multiple interactions |
EXP |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
multiple interactions |
EXP |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
multiple interactions |
EXP |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Amotl2 |
angiomotin like 2 |
|
multiple interactions |
EXP |
8 |
107,694,405 |
107,709,841 |
RGD:6480464 |
CTD |
| G |
Arhgef11 |
Rho guanine nucleotide exchange factor (GEF) 11 |
|
multiple interactions |
EXP |
2 |
179,676,236 |
179,796,785 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
multiple interactions |
EXP |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
multiple interactions |
EXP |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
multiple interactions |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
multiple interactions |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
multiple interactions |
EXP |
4 |
144,139,486 |
144,145,186 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
EXP |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
EXP |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
EXP |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
multiple interactions |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
multiple interactions |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases expression |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccnl1 |
cyclin L1 |
|
multiple interactions |
EXP |
2 |
155,757,335 |
155,769,633 |
RGD:6480464 |
CTD |
| G |
Ccrn4l |
CCR4 carbon catabolite repression 4-like (S. cerevisiae) |
|
multiple interactions |
EXP |
2 |
140,120,310 |
140,140,518 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
multiple interactions |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
multiple interactions |
EXP |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
multiple interactions |
EXP |
17 |
62,770,633 |
62,837,670 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
EXP |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
multiple interactions |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases expression |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcr7 |
chemokine (C-X-C motif) receptor 7 |
|
multiple interactions |
EXP |
9 |
89,343,528 |
89,355,053 |
RGD:6480464 |
CTD |
| G |
Cxcr7 |
chemokine (C-X-C motif) receptor 7 |
|
multiple interactions |
EXP |
9 |
89,343,528 |
89,355,053 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
multiple interactions |
EXP |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Dio3 |
deiodinase, iodothyronine, type III |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
multiple interactions |
EXP |
2 |
181,444,599 |
181,451,944 |
RGD:6480464 |
CTD |
| G |
Egfl7 |
EGF-like-domain, multiple 7 |
|
multiple interactions |
EXP |
3 |
4,760,574 |
4,769,909 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
multiple interactions |
EXP |
6 |
74,451,038 |
74,476,506 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
multiple interactions |
EXP |
6 |
74,451,038 |
74,476,506 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
multiple interactions |
EXP |
6 |
74,451,038 |
74,476,506 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
multiple interactions |
EXP |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
multiple interactions |
EXP |
4 |
163,468,604 |
163,476,325 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
affects metabolic processing |
ISO |
13 |
78,659,513 |
78,678,524 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
multiple interactions |
EXP |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
multiple interactions |
EXP |
2 |
46,542,246 |
46,550,678 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
affects expression |
ISO |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
multiple interactions |
EXP |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
multiple interactions |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gzmb |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
multiple interactions |
EXP |
15 |
35,195,075 |
35,198,506 |
RGD:6480464 |
CTD |
| G |
Gzmbl2 |
Granzyme B-like 2 |
|
multiple interactions |
EXP |
15 |
35,061,676 |
35,074,048 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hoxa5 |
homeo box A5 |
|
multiple interactions |
EXP |
4 |
80,501,675 |
80,504,626 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
EXP |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
decreases activity |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspb8 |
heat shock protein B8 |
|
multiple interactions |
EXP |
12 |
41,407,166 |
41,421,565 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
multiple interactions |
EXP |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id4 |
inhibitor of DNA binding 4 |
|
multiple interactions |
EXP |
17 |
22,525,292 |
22,527,861 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Igsf10 |
immunoglobulin superfamily, member 10 |
|
multiple interactions |
EXP |
2 |
148,704,646 |
148,734,103 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
multiple interactions |
EXP |
7 |
67,308,713 |
67,310,138 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
multiple interactions |
EXP |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
multiple interactions |
EXP |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
multiple interactions |
EXP |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Itpkc |
inositol-trisphosphate 3-kinase C |
|
multiple interactions |
EXP |
1 |
82,284,846 |
82,306,422 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
EXP |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
EXP |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
EXP |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
multiple interactions |
EXP |
17 |
75,578,498 |
75,585,072 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
multiple interactions |
EXP |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
increases expression |
EXP |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
multiple interactions |
EXP |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
decreases expression |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
multiple interactions |
EXP |
18 |
61,134,242 |
61,477,040 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
multiple interactions |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
multiple interactions |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
P4ha1 |
prolyl 4-hydroxylase, alpha polypeptide I |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pfkl |
phosphofructokinase, liver |
|
multiple interactions |
EXP |
20 |
11,009,359 |
11,032,511 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
multiple interactions |
EXP |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Preb |
prolactin regulatory element binding |
|
multiple interactions |
EXP |
6 |
25,401,759 |
25,405,561 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
affects expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
multiple interactions |
EXP |
1 |
79,213,654 |
79,229,063 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
EXP |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
affects activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
multiple interactions |
EXP |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rgs4 |
regulator of G-protein signaling 4 |
|
multiple interactions |
EXP |
13 |
85,533,882 |
85,540,173 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
|
multiple interactions |
EXP |
7 |
127,817,026 |
127,877,875 |
RGD:6480464 |
CTD |
| G |
Sik1 |
salt-inducible kinase 1 |
|
multiple interactions |
EXP |
20 |
10,282,203 |
10,291,735 |
RGD:6480464 |
CTD |
| G |
Slc16a6 |
solute carrier family 16, member 6 (monocarboxylic acid transporter 7) |
|
multiple interactions |
EXP |
10 |
98,853,289 |
98,875,189 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
multiple interactions |
EXP |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
multiple interactions |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
increases uptake |
EXP |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
affects transport |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases uptake |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
multiple interactions |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases uptake |
EXP |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
increases uptake |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
increases uptake |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
multiple interactions |
EXP |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc38a2 |
solute carrier family 38, member 2 |
|
multiple interactions |
EXP |
7 |
135,365,172 |
135,377,341 |
RGD:6480464 |
CTD |
| G |
Slc5a3 |
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
|
multiple interactions |
EXP |
11 |
32,063,275 |
32,065,721 |
RGD:6480464 |
CTD |
| G |
Slk |
STE20-like kinase |
|
multiple interactions |
EXP |
1 |
252,954,514 |
253,007,330 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
multiple interactions |
EXP |
10 |
106,641,509 |
106,645,579 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases expression |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
multiple interactions |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
multiple interactions |
EXP |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tpm3 |
tropomyosin 3 |
|
multiple interactions |
EXP |
2 |
182,303,994 |
182,324,994 |
RGD:6480464 |
CTD |
| G |
Trak2 |
trafficking protein, kinesin binding 2 |
|
multiple interactions |
EXP |
9 |
57,474,682 |
57,540,751 |
RGD:6480464 |
CTD |
| G |
Ube2b |
ubiquitin-conjugating enzyme E2B |
|
multiple interactions |
EXP |
10 |
37,509,322 |
37,523,900 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Zbtb10 |
zinc finger and BTB domain containing 10 |
|
multiple interactions |
EXP |
2 |
94,538,617 |
94,569,036 |
RGD:6480464 |
CTD |
| G |
Zfyve27 |
zinc finger, FYVE domain containing 27 |
|
multiple interactions |
EXP |
1 |
248,663,072 |
248,683,668 |
RGD:6480464 |
CTD |
Term paths to the root
|